| Online-Ressource |
Verfasst von: | Kremer, Jamila [VerfasserIn]  |
| Farag, Mina [VerfasserIn]  |
| Brcic, Andreas [VerfasserIn]  |
| Zubarevich, Alina [VerfasserIn]  |
| Schamroth, Joel [VerfasserIn]  |
| Kreußer, Michael [VerfasserIn]  |
| Karck, Matthias [VerfasserIn]  |
| Ruhparwar, Arjang [VerfasserIn]  |
| Schmack, Bastian [VerfasserIn]  |
Titel: | Temporary right ventricular circulatory support following right ventricular infarction |
Titelzusatz: | results of a groin-free approach |
Verf.angabe: | Jamila Kremer, Mina Farag, Andreas Brcic, Alina Zubarevich, Joel Schamroth, Michael M. Kreusser, Matthias Karck, Arjang Ruhparwar and Bastian Schmack |
E-Jahr: | 2020 |
Jahr: | 5 August 2020 |
Umfang: | 18 S. |
Teil: | volume:7 |
| year:2020 |
| number:5 |
| pages:2853-2861 |
| extent:18 |
Fussnoten: | Gesehen am 08.09.2021 |
Titel Quelle: | Enthalten in: European Society of CardiologyESC heart failure |
Ort Quelle: | Chichester : Wiley, 2014 |
Jahr Quelle: | 2020 |
Band/Heft Quelle: | 7(2020), 5, Seite 2853-2861 |
ISSN Quelle: | 2055-5822 |
Abstract: | Aims Acute right heart failure (RHF) is a severe complication of right ventricular infarction. The management of acute RHF poses a number of challenges, such as providing haemodynamic support. Temporary circulatory support (TCS) may be required upon failing medical therapy. The ProtekDuo® dual lumen cannula provides a minimally invasive option for (TCS) through a groin-free internal jugular vein approach. We present the largest patient series to date using the ProtekDuo® cannula as temporary right ventricular assist device (t-RVAD) in RHF after acute myocardial infarction (MI). Methods and results From July 2016 to November 2019, 10 patients underwent t-RVAD implantation for RHF following acute MI. Transthoracic and transoesophageal echocardiography were performed in all patients to assess cardiac function, with a particular focus on RV function. Cumulative 30-day survival was 60%. Mean TAPSE was 6.4 ± 3.1 mm, mean fractional area change was 12.1 ± 4.2%, and mean right ventricular end diastolic area was 19.8 ± 2.7 cm2. Mean implantation time was 32.8 ± 8.3 min. Mean interval after first cardiac intervention was 4.6 ± 5.8 days. Mean t-RVAD time was 10.0 ± 7.4 days with a significant reduction in central venous pressure 19.3 ± 2.7 vs. 8.2 ± 2.6 mmHg, P < 0.001 and a significant increase in central venous saturation 52.8 ± 15.6 vs. 80.0 ± 6.0%, P < 0.001. Mean intensive care unit stay was 18.6 ± 12.2 days. Four patients were weaned from TCS. Two patients were bridged to a long-term paracorporeal RVAD. There were no t-RVAD associated complications. Causes of death (n = 4) were multiorgan failure, electromechanical dissociation, and haemorrhagic stroke. Mean follow-up time was 96.0 ± 107.6 days. No independent predictors of mortality were identified in univariate analysis. Conclusions We show that groin-free, percutaneous implantation of the ProtekDuo® cannula is a feasible and safe tool for TCS in acute RHF post-MI. This approach provides the advantages of percutaneous implantation including complete mobilization and non-surgical bedside explantation, as well as the option for adding an oxygenator to the t-RVAD circuit. |
DOI: | doi:10.1002/ehf2.12888 |
URL: | kostenfrei: Volltext ; Verlag: https://doi.org/10.1002/ehf2.12888 |
| kostenfrei: Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/ehf2.12888 |
| DOI: https://doi.org/10.1002/ehf2.12888 |
Datenträger: | Online-Ressource |
Sprache: | eng |
Sach-SW: | Assist device |
| Myocardial infarction |
| Percutaneous implantation |
| Temporary circulatory support |
K10plus-PPN: | 1769673814 |
Verknüpfungen: | → Zeitschrift |
|
|
| |
Lokale URL UB: | Zum Volltext |
Temporary right ventricular circulatory support following right ventricular infarction / Kremer, Jamila [VerfasserIn]; 5 August 2020 (Online-Ressource)